Showing results (1331-1340 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|March 4, 2005
A phase II trial of ZD1839 (Iressa) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancerMary J Mackenzie, Holger W Hirte, Goss Glenwood, et al.
Investigational New Drugs|May 4, 2005
Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulamCharlotte van Kesteren, Anthe S Zandvliet, Mats O Karlsson, et al.
Investigational New Drugs|May 4, 2005
Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancerJohan Vansteenkiste, Jean-Luc Canon, Henrik Riska, et al.
Investigational New Drugs|March 1, 2006
Effects of the potential chemopreventive agent DMU-135 on adenoma development in the ApcMin+ mouseS Sale, R G Tunstall, K C Ruparelia, et al.
Investigational New Drugs|January 25, 2008
A phase I trial of CEP-701 + gemcitabine in patients with advanced adenocarcinoma of the pancreasEmily Chan, Daniel Mulkerin, Mace Rothenberg, et al.
Investigational New Drugs|March 7, 2008
Modulation of key signal transduction molecules by a novel peptide combination effective for the treatment of gastrointestinal carcinomasAnu T Singh, Manu Jaggi, Sudhanand Prasad, et al.
Investigational New Drugs|August 1, 1991
Phase II evaluation of menogaril in patients with advanced hypernephromaH J Long, M D Hauge, T M Therneau, et al.
Investigational New Drugs|March 28, 2008
Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinomaByeong-Bae Park, Young-Hyuck Im, In Gyu Hwang, et al.
Investigational New Drugs|March 13, 2008
Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforationJ Tol, A Cats, L Mol, et al.
Investigational New Drugs|February 29, 2008
A phase II study of pemetrexed in patients with advanced hepatocellular carcinomaAllen L Cohn, J William Myers, Steven Mamus, et al.
Pageof 372